Spatial -omics technologies: the new enterprise in 3D breast cancer models.

[1]  J. Laskin,et al.  Nano-DESI Mass Spectrometry Imaging of Proteoforms in Biological Tissues with High Spatial Resolution. , 2023, Analytical chemistry.

[2]  R. Heeren,et al.  A Multimodal SIMS/MALDI Mass Spectrometry Imaging Source with Secondary Electron Imaging Capabilities for Use with timsTOF Instruments , 2023, Journal of the American Society for Mass Spectrometry.

[3]  T. Voet,et al.  Methods and applications for single-cell and spatial multi-omics , 2023, Nature Reviews Genetics.

[4]  Laura M. Heiser,et al.  A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs , 2022, Nature biotechnology.

[5]  C. Plass,et al.  Cell line authentication: a necessity for reproducible biomedical research , 2022, The EMBO journal.

[6]  J. Otero,et al.  Bioprinting Decellularized Breast Tissue for the Development of Three-Dimensional Breast Cancer Models , 2022, ACS applied materials & interfaces.

[7]  C. C. Eylem,et al.  Omics technologies for high-throughput-screening of cell-biomaterial interactions. , 2022, Molecular Omics.

[8]  P. Boukany,et al.  Microfluidics meets 3D cancer cell migration. , 2022, Trends in cancer.

[9]  A. Hamers,et al.  CyTOF® for the Masses , 2022, Frontiers in Immunology.

[10]  F. Vadillo-Ortega,et al.  Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model , 2022, PloS one.

[11]  Hyunwook Kang,et al.  In vitro breast cancer model with patient-specific morphological features for personalized medicine , 2022, Biofabrication.

[12]  A. Vanhoestenberghe,et al.  Urgent action is required to increase sustainability in in vitro modelling , 2022, In vitro models.

[13]  Gabor T. Marth,et al.  A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology , 2022, Nature Cancer.

[14]  P. Babál,et al.  Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[16]  Q. Gao,et al.  Spatial omics: Navigating to the golden era of cancer research , 2022, Clinical and translational medicine.

[17]  G. Urban,et al.  Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures. , 2021, Lab on a chip.

[18]  Amani Zoabi,et al.  Desorption electrospray ionization mass spectrometry imaging in discovery and development of novel therapies. , 2021, Mass spectrometry reviews.

[19]  D. Cescon,et al.  Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies , 2021, Advanced healthcare materials.

[20]  Stephen R. Williams,et al.  A single-cell and spatially resolved atlas of human breast cancers , 2021, Nature Genetics.

[21]  M. Sarfaty,et al.  Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer , 2021, Breast.

[22]  David R. Jones,et al.  Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients , 2021, Cell.

[23]  Randy E. Ellis,et al.  Metabolomics patterns of breast cancer tumors using mass spectrometry imaging , 2021, International Journal of Computer Assisted Radiology and Surgery.

[24]  A. Beyer,et al.  Deciphering the signaling network of breast cancer improves drug sensitivity prediction. , 2021, Cell systems.

[25]  Michael J Taylor,et al.  Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics , 2021, Journal of the American Society for Mass Spectrometry.

[26]  C. Lim,et al.  Microfluidic studies of hydrostatic pressure-enhanced doxorubicin resistance in human breast cancer cells. , 2021, Lab on a chip.

[27]  Robert J. Schmitz,et al.  Chromatin accessibility profiling methods , 2021, Nature Reviews Methods Primers.

[28]  W. Woodward,et al.  Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer , 2021, Communications biology.

[29]  H. Phatnani,et al.  Spatially resolved transcriptomics and its applications in cancer. , 2021, Current opinion in genetics & development.

[30]  Tyler T. Risom,et al.  Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma , 2021, Cell.

[31]  G. Plitas,et al.  Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype , 2021, Annals of Surgical Oncology.

[32]  J. Mano,et al.  Screening of dual chemo-Photothermal cellular Nanotherapies in Organotypic breast Cancer 3D spheroids. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[33]  M. Conconi,et al.  Breast Cancer Cell Cultures on Electrospun Poly(ε-Caprolactone) as a Potential Tool for Preclinical Studies on Anticancer Treatments , 2020, Bioengineering.

[34]  Shu-juan Xie,et al.  RNA sequencing: new technologies and applications in cancer research , 2020, Journal of Hematology & Oncology.

[35]  C. Tripodo,et al.  Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment , 2020, Cancers.

[36]  A. Gasbarrini,et al.  Development and characterization of a novel human 3D model of bone metastasis from breast carcinoma in vitro cultured and retaining the in vivo tumor microenvironment and cell heterogeneity. , 2020, Bone.

[37]  Jaana M. Hartikainen,et al.  Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. , 2021, The New England journal of medicine.

[38]  Jake A Melby,et al.  Top-down proteomics: challenges, innovations, and applications in basic and clinical research , 2020, Expert review of proteomics.

[39]  Han-Byoel Lee,et al.  Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type , 2020, Breast Cancer Research and Treatment.

[40]  Andrew D. Wong,et al.  A Tissue-Engineered 3D Microvessel Model Reveals the Dynamics of Mosaic Vessel Formation in Breast Cancer , 2020, Cancer Research.

[41]  S. Takayama,et al.  Cancer Cell Invasion of Mammary Organoids with Basal‐In Phenotype , 2020, Advanced healthcare materials.

[42]  W. Murphy,et al.  Synthetic alternatives to Matrigel , 2020, Nature Reviews Materials.

[43]  P. Buckhaults,et al.  Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer , 2020, Nature Communications.

[44]  Joseph Bergenstråhle,et al.  Spatially Resolved Transcriptomes—Next Generation Tools for Tissue Exploration , 2020, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  J. A. van der Laak,et al.  Histological subtypes in triple negative breast cancer are associated with specific information on survival. , 2020, Annals of Diagnostic Pathology.

[46]  C. Gomillion,et al.  Bioprinted Three-Dimensional Cell-Laden Hydrogels to Evaluate Adipocyte-Breast Cancer Cell Interactions , 2020, Gels.

[47]  G. Cserni.  Histological type and typing of breast carcinomas and the WHO classification changes over time , 2020, Pathologica.

[48]  S. Kidoaki,et al.  Characterization of 3D matrix conditions for cancer cell migration with elasticity/porosity-independent tunable microfiber gels , 2020, Polymer Journal.

[49]  P R LeDuc,et al.  Tumor-on-a-chip for integrating a 3D tumor microenvironment: chemical and mechanical factors. , 2020, Lab on a chip.

[50]  R. Puga,et al.  Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. , 2020, Materials science & engineering. C, Materials for biological applications.

[51]  Cathryn M. Gould,et al.  Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer , 2020, Nature Communications.

[52]  S. Varghese,et al.  An engineered tumor-on-a-chip device with breast cancer-immune cell interactions for assessing T-cell recruitment. , 2019, Cancer research.

[53]  Ahmedin Jemal,et al.  Breast cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[54]  Gail A. Van Norman,et al.  Limitations of Animal Studies for Predicting Toxicity in Clinical Trials , 2019, JACC. Basic to translational science.

[55]  Koichi Nishiyama,et al.  Vascularized cancer on a chip: The effect of perfusion on growth and drug delivery of tumor spheroid. , 2019, Biomaterials.

[56]  J. Visvader,et al.  Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids. , 2019, Journal of the National Cancer Institute.

[57]  J. Fredberg,et al.  Cell swelling, softening and invasion in a three-dimensional breast cancer model , 2019, Nature Physics.

[58]  Joel S. Bader,et al.  E-cadherin is required for metastasis in multiple models of breast cancer , 2019, Nature.

[59]  Peter A Mollica,et al.  3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels. , 2019, Acta biomaterialia.

[60]  K. Chatterjee,et al.  Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy. , 2019, Colloids and surfaces. B, Biointerfaces.

[61]  Gary D Bader,et al.  Benchmarking to the Gold Standard: Hyaluronan‐Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid Culture , 2019, Advanced materials.

[62]  Yongxiang Luo,et al.  3D printing of hydrogel scaffolds for future application in photothermal therapy of breast cancer and tissue repair. , 2019, Acta biomaterialia.

[63]  Y. S. Zhang,et al.  Sacrificial Bioprinting of a Mammary Ductal Carcinoma Model. , 2019, Biotechnology journal.

[64]  Patrick A. Newbury,et al.  Evaluating cell lines as models for metastatic breast cancer through integrative analysis of genomic data , 2019, Nature Communications.

[65]  Aaron E. Chiou,et al.  Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression , 2019, ACS central science.

[66]  J. LaBaer,et al.  A Human Organotypic Microfluidic Tumor Model Permits Investigation of the Interplay between Patient-Derived Fibroblasts and Breast Cancer Cells. , 2019, Cancer research.

[67]  Scott N. Mueller,et al.  Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging. , 2019, Cancer cell.

[68]  R. Kamm,et al.  The effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model. , 2019, Biomaterials.

[69]  Y. Wan,et al.  Incorporation of hydroxyapatite into nanofibrous PLGA scaffold towards improved breast cancer cell behavior , 2019, Materials Chemistry and Physics.

[70]  F. Lu,et al.  Adipose-derived mesenchymal stem cells exhibit tumor tropism and promote tumorsphere formation of breast cancer cells , 2019, Oncology reports.

[71]  K. D. Duncan,et al.  Advances in mass spectrometry based single-cell metabolomics. , 2019, The Analyst.

[72]  Wei Sun,et al.  Bioprinting of 3D breast epithelial spheroids for human cancer models , 2019, Biofabrication.

[73]  Jessica K. Chang,et al.  YAP-independent mechanotransduction drives breast cancer progression , 2018, Nature Communications.

[74]  Dan Gao,et al.  A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems. , 2018, Analytica chimica acta.

[75]  Tiffany M. Heaster,et al.  Organotypic microfluidic breast cancer model reveals starvation-induced spatial-temporal metabolic adaptations , 2018, EBioMedicine.

[76]  M. Distefano,et al.  Photo-immobilized EGF chemical gradients differentially impact breast cancer cell invasion and drug response in defined 3D hydrogels. , 2018, Biomaterials.

[77]  Pinar Zorlutuna,et al.  Stromal cell-laden 3D hydrogel microwell arrays as tumor microenvironment model for studying stiffness dependent stromal cell-cancer interactions. , 2018, Biomaterials.

[78]  Danh Truong,et al.  Microfluidic Tumor–Vascular Model to Study Breast Cancer Cell Invasion and Intravasation , 2018, Advanced healthcare materials.

[79]  S. Scaglione,et al.  A new cell-laden 3D Alginate-Matrigel hydrogel resembles human breast cancer cell malignant morphology, spread and invasion capability observed “in vivo” , 2018, Scientific Reports.

[80]  Hans Clevers,et al.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.

[81]  G. Curigliano,et al.  Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life. , 2019, Critical reviews in oncology/hematology.